The Serendipitous Story of SGLT2 Inhibitors in Heart Failure
Author:
Affiliation:
1. Division of Cardiac Surgery, St Michael’s Hospital, University of Toronto, Canada (S.V.).
2. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (J.J.V.M.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference16 articles.
1. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
2. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
3. Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction
4. Influence of microvascular disease on cardiovascular events in type 2 diabetes [published online March 15, 2019].;Verma S;J Am Coll Cardiol
5. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer;Texas Heart Institute Journal;2024-04-09
2. Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk;Journal of Clinical Medicine;2024-01-29
3. Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis;World Journal of Nephrology;2023-12-25
4. Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling;American Journal of Physiology-Heart and Circulatory Physiology;2023-11-01
5. Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction;European Heart Journal;2023-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3